학술논문
Antibody level dynamics until after the third dose of COVID-19 vaccination
Document Type
article
Author
Source
Heliyon, Vol 9, Iss 7, Pp e17477- (2023)
Subject
Language
English
ISSN
2405-8440
Abstract
The antibody titers of volunteers, including elderly people, were investigated after the second dose of the BNT162b2 vaccine (Pfizer-BioNTech) as an mRNA vaccine against the coronavirus disease 2019 (COVID-19). Serum samples were collected from 105 volunteers (44 healthcare workers and 61 elderly people) 7–14 days after the second vaccine dose, and antibody titers were measured. The antibody titers of study participants in their 20s were significantly higher than those of other age groups. Furthermore, the antibody titers of participants aged